The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Osteoporosis in inflammatory joint diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856 · cited 1×
“T lymphocytes stimulate osteoclast formation [63], and Treg cells suppress this phenomenon [64].”
BackgroundSato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 1×
“TNF is able to increase bone resorption only in the presence of permissive amounts of RANK L [ 71 ].”
BackgroundClinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.
Staa, T. P. V., Geusens, P., Bijlsma, J. W. J., Leufkens, H. G. M., & Cooper, C. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22117 · Cited by 587 · cited 9×
“Using the General Practice Research Database [1], 30,262 patients with RA (ages ≥40 years) were compared to controls, with a mean duration of follow-up of 4.3 years; the increased risk of clinical fracture was 1.5 (1.4–1.6), as shown in other population-based studies [4].”
BackgroundMethodResultInfluentialOsteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo
Axmann, R., Böhm, C., Krönke, G., Zwerina, J., Smolen, J., & Schett, G. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24781 · Cited by 263 · cited 1×
“Their pivotal role is demonstrated by studies of cytokine blockers: bone resorption and osteoclast formation can be inhibited by anti-IL6 [75], anti-TNF [76], and osteoprotegerin [77].”
BackgroundHunter, D. J., Gerstenfeld, L., Bishop, G., Davis, A. D., Mason, Z. D., Einhorn, T. A., Maciewicz, R. A., Newham, P., Foster, M., Jackson, S., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2601 · Cited by 214
Lodder, M. C., de Jong, Z., Kostense, P. J., Molenaar, E. T. H., Staal, K., Voskuyl, A. E., Hazes, J. M. W., Dijkmans, B. A. C., & Lems, W. F. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.016253 · Cited by 202 · cited 2×
“This prevalence is in the order of 20–30% at the spine and 7– 26% at the hip [10, 13, 23, 29, 30].”
BackgroundGeusens, P. P., Landewé, R. B. M., Garnero, P., Chen, D., Dunstan, C. R., Lems, W. F., Stinissen, P., van der Heijde, D. M. F. M., van der Linden, S., & Boers, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21896 · Cited by 182
Pettit, A. R., Walsh, N. C., Manning, C., Goldring, S. R., & Gravallese, E. M. (2006) · Rheumatology · doi:10.1093/rheumatology/kel045 · Cited by 151 · cited 1×
“RANK ligand is expressed at the pannus–bone interface at sites of bone erosion [67].”
BackgroundOsteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice.
Schett, G., Redlich, K., Hayer, S., Zwerina, J., Bolon, B., Dunstan, C., Görtz, B., Schulz, A., Bergmeister, H., Kollias, G., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11150 · Cited by 150 · cited 1×
“RANK L has a permissive effect on the osteoclastogenesis effect of TNF, and osteoprotegerin protects against TNFinduced bone loss [ 70 ].”
BackgroundSaidenberg-Kermanac'h, N., Corrado, A., Lemeiter, D., deVernejoul, M. C., Boissier, M. C., & Cohen-Solal, M. E. (2004) · Bone · doi:10.1016/j.bone.2004.07.004 · Cited by 117 · cited 1×
“Their pivotal role is demonstrated by studies of cytokine blockers: bone resorption and osteoclast formation can be inhibited by anti-IL6 [75], anti-TNF [76], and osteoprotegerin [77].”
Background
Cited by
A comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Kamali Dehghan, B., Kamarehei, M., & Yong Meng, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 597
The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB
Moreno, J. A., Izquierdo, M. C., Sanchez-Niño, M. D., Suárez-Alvarez, B., Lopez-Larrea, C., Jakubowski, A., Blanco, J., Ramirez, R., Selgas, R., Ruiz-Ortega, M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101073 · Cited by 388
Glucocorticoid-induced osteoporosis
Briot, K., & Roux, C. (2015) · RMD Open · doi:10.1136/rmdopen-2014-000014 · Cited by 300
Self-citation
Metadata
- Authors
- Roux, C.
- Venue
- Osteoporosis International
- Published
- 2010-06-15
- Volume
- 22
- Issue
- 2
- Pages
- 421-433
- ISSN
- 0937-941X (ISSN-L)
- 1433-2965
- OpenAlex
- W2068057432
- Cited by
- 180
- References
- 12
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.